We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEX icon
2026
Terex
TEX
$7.74B
– –
-11,616
Closed -$615K
TFSL icon
2027
TFS Financial
TFSL
$4.93B
– –
-48,110
Closed -$619K
TGI
2028
DELISTED
Triumph Group
TGI
– –
-26,374
Closed -$340K
TGTX icon
2029
TG Therapeutics
TGTX
$7.62B
– –
-10,987
Closed -$257K
THG icon
2030
Hanover Insurance
THG
$7.98B
– –
-9,986
Closed -$1.48M
TMCI icon
2031
Treace Medical Concepts
TMCI
$309M
– –
-149,129
Closed -$865K
TNYA icon
2032
Tenaya Therapeutics
TNYA
$163M
– –
-147,932
Closed -$286K
TPH
2033
DELISTED
Tri Pointe Homes
TPH
– –
-6,189
Closed -$280K
TPR icon
2034
Tapestry
TPR
$32.8B
– –
-5,045
Closed -$237K
TPST icon
2035
Tempest Therapeutics
TPST
$14.6M
– –
-7,301
Closed -$133K
TRDA icon
2036
Entrada Therapeutics
TRDA
$267M
– –
-36,577
Closed -$585K
TREX icon
2037
Trex
TREX
$5.01B
– –
-9,397
Closed -$626K
TRUE
2038
DELISTED
TrueCar
TRUE
– –
-97,464
Closed -$336K
TSCO icon
2039
Tractor Supply
TSCO
$18.1B
– –
-8,140
Closed -$474K
TSHA icon
2040
Taysha Gene Therapies
TSHA
$1.89B
– –
-233,560
Closed -$469K
TWST icon
2041
Twist Bioscience
TWST
$7.25B
– –
-4,994
Closed -$226K
TZOO icon
2042
Travelzoo
TZOO
$75.4M
– –
-14,083
Closed -$170K
U icon
2043
Unity
U
$18.9B
– –
-16,799
Closed -$380K
UE icon
2044
Urban Edge Properties
UE
$2.73B
– –
-64,042
Closed -$1.37M
UGI icon
2045
UGI
UGI
$7.33B
– –
-11,254
Closed -$282K
UIS icon
2046
Unisys
UIS
$217M
– –
-365,589
Closed -$2.08M
UNFI icon
2047
United Natural Foods
UNFI
$2.85B
– –
-22,537
Closed -$379K
UNM icon
2048
Unum
UNM
$14.3B
– –
-27,090
Closed -$1.61M
UPBD icon
2049
Upbound Group
UPBD
$1.16B
– –
-9,413
Closed -$301K
URGN icon
2050
UroGen Pharma
URGN
$2.29B
– –
-19,597
Closed -$249K
80 81
82
83 84

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.